1315 Capital acquires Argonaut’s life sciences and diagnostics unit
The divested unit, now operating independently as Aluris Sciences, provides contract manufacturing for life sciences, diagnostics and combination drug product customers from formulation through commercial production. The post 1315 Capital acquires Argonaut’s life sciences and diagnostics unit appeared first on PE Hub .
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.